Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China
· Delayed Price · Currency is CNY 26.41
+0.26 (0.99%)
Apr 29, 2026, 11:29 AM CST
SHA:600645 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,421 | 1,455 | 1,550 | 1,538 | 1,507 | 1,497 | Upgrade
|
| Other Revenue | - | - | 35.81 | 52.07 | 47.8 | 37.94 | Upgrade
|
| Revenue | 1,421 | 1,455 | 1,585 | 1,590 | 1,555 | 1,535 | Upgrade
|
| Revenue Growth (YoY) | -7.59% | -8.23% | -0.27% | 2.24% | 1.27% | 16.41% | Upgrade
|
| Cost of Revenue | 424.22 | 438.8 | 497.75 | 505.02 | 510.29 | 473.84 | Upgrade
|
| Gross Profit | 997.27 | 1,016 | 1,088 | 1,085 | 1,045 | 1,061 | Upgrade
|
| Selling, General & Admin | 642.95 | 654.87 | 695.33 | 719.77 | 723.4 | 749.78 | Upgrade
|
| Research & Development | 146.05 | 149.01 | 182.11 | 184.49 | 146.12 | 133.85 | Upgrade
|
| Other Operating Expenses | 13.07 | 15.72 | 19.39 | 19.19 | 17.59 | 16.54 | Upgrade
|
| Operating Expenses | 802.07 | 819.6 | 924.48 | 946.57 | 901.67 | 937.05 | Upgrade
|
| Operating Income | 195.2 | 196.55 | 163.2 | 138.14 | 142.93 | 124.44 | Upgrade
|
| Interest Expense | - | - | -5.03 | -5.02 | -4.02 | -3.14 | Upgrade
|
| Interest & Investment Income | - | - | 24.4 | 29.59 | 18.23 | 16.21 | Upgrade
|
| Earnings From Equity Investments | 2.21 | - | -14.3 | -11.85 | -7.96 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -3.2 | 1.51 | -2.37 | 0.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.52 | -5.49 | -3.22 | 1.03 | -2 | -1.49 | Upgrade
|
| EBT Excluding Unusual Items | 191.9 | 191.06 | 161.84 | 153.4 | 144.82 | 136.13 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -19.72 | Upgrade
|
| Gain (Loss) on Sale of Investments | -6.91 | -7.92 | -30.03 | -36.09 | -0.75 | 79.09 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.59 | 6.41 | 1.3 | 3.67 | 2.03 | 0.51 | Upgrade
|
| Asset Writedown | -16.13 | -15.11 | -4.68 | -0.31 | -0.8 | -6.26 | Upgrade
|
| Other Unusual Items | - | - | 7.52 | 11.92 | 9.9 | 33.2 | Upgrade
|
| Pretax Income | 175.45 | 174.45 | 135.95 | 132.59 | 155.21 | 222.96 | Upgrade
|
| Income Tax Expense | 73.32 | 70.92 | 46.59 | 34.03 | 48.53 | 71.75 | Upgrade
|
| Earnings From Continuing Operations | 102.13 | 103.53 | 89.35 | 98.55 | 106.68 | 151.21 | Upgrade
|
| Minority Interest in Earnings | 7.91 | 10.3 | 11 | 7.9 | 6.3 | 4.11 | Upgrade
|
| Net Income | 110.05 | 113.83 | 100.35 | 106.45 | 112.99 | 155.32 | Upgrade
|
| Net Income to Common | 110.05 | 113.83 | 100.35 | 106.45 | 112.99 | 155.32 | Upgrade
|
| Net Income Growth | 24.72% | 13.43% | -5.73% | -5.78% | -27.26% | - | Upgrade
|
| Shares Outstanding (Basic) | 460 | 455 | 456 | 463 | 471 | 471 | Upgrade
|
| Shares Outstanding (Diluted) | 460 | 455 | 456 | 463 | 471 | 471 | Upgrade
|
| Shares Change (YoY) | -0.36% | -0.18% | -1.45% | -1.69% | 0.02% | 0.17% | Upgrade
|
| EPS (Basic) | 0.24 | 0.25 | 0.22 | 0.23 | 0.24 | 0.33 | Upgrade
|
| EPS (Diluted) | 0.24 | 0.25 | 0.22 | 0.23 | 0.24 | 0.33 | Upgrade
|
| EPS Growth | 25.17% | 13.64% | -4.35% | -4.17% | -27.27% | - | Upgrade
|
| Free Cash Flow | 248.55 | 264.07 | 217.87 | 210.4 | 162.7 | 193.22 | Upgrade
|
| Free Cash Flow Per Share | 0.54 | 0.58 | 0.48 | 0.46 | 0.35 | 0.41 | Upgrade
|
| Gross Margin | 70.16% | 69.84% | 68.61% | 68.23% | 67.18% | 69.14% | Upgrade
|
| Operating Margin | 13.73% | 13.51% | 10.29% | 8.69% | 9.19% | 8.11% | Upgrade
|
| Profit Margin | 7.74% | 7.82% | 6.33% | 6.70% | 7.27% | 10.12% | Upgrade
|
| Free Cash Flow Margin | 17.48% | 18.15% | 13.74% | 13.23% | 10.46% | 12.58% | Upgrade
|
| EBITDA | 343.77 | 335.87 | 265.53 | 281.74 | 253.74 | 227.35 | Upgrade
|
| EBITDA Margin | 24.18% | 23.09% | 16.75% | 17.72% | 16.32% | 14.81% | Upgrade
|
| D&A For EBITDA | 148.57 | 139.32 | 102.33 | 143.6 | 110.81 | 102.91 | Upgrade
|
| EBIT | 195.2 | 196.55 | 163.2 | 138.14 | 142.93 | 124.44 | Upgrade
|
| EBIT Margin | 13.73% | 13.51% | 10.29% | 8.69% | 9.19% | 8.11% | Upgrade
|
| Effective Tax Rate | 41.79% | 40.65% | 34.27% | 25.67% | 31.26% | 32.18% | Upgrade
|
| Revenue as Reported | - | - | 1,585 | 1,590 | 1,555 | 1,535 | Upgrade
|
| Advertising Expenses | - | - | 30.86 | 32.98 | 29.02 | 32.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.